Curasan AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other
pharmaceutical manufacturers in Europe:
Transgene
of France
(2016
sales of 8.73 million Euro [US$10.80 million]
of which 72%
was Research & Development Tax Credit),
Co Don AG
(5.60 million Euro [US$6.93 million]
of which 100%
was Product sales), and
Biomed Lublin Wytwornia Surowic I Szczepionek SA
which is
based in Poland
(36.34 million Polish New Zlotys [US$10.80 million]
of which 76%
was Traditional Segment).
Sales Analysis.
Curasan AG reported sales of 6.50 million Euro (US$8.05 million)
for the
year ending
December of 2016.
This
represents
an
increase of 15.8%
versus 2015, when the company's sales were 5.62 million Euro.